EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Crocodile tear syndrome treated with lacrimal gland incobotulinum toxin A injection: a case series

Kathleen Krivda, Carson Clabeaux, Vladimir Yakopson

Digital Journal of Ophthalmology · 2023

DOI: 10.5693/djo.02.2023.09.001 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Digital Journal of Ophthalmology, 2023. Verfasst von Kathleen Krivda und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Uniformed Services University, Bethesda, Maryland. Hauptthemen laut MEDLINE: Lacrimal Apparatus, Botulinum Toxins, Type A, Neuromuscular Agents, Lacrimal Apparatus Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Crocodile Tear Syndrome (CTS) is a late complication of Cranial Nerve VII (CNVII) palsy characterized by unilateral lacrimation in response to gustatory stimulation. We present a retrospective case series of two patients who were diagnosed with Crocodile Tear Syndrome after recovering from unilateral idiopathic Cranial Nerve VII (CNVII) palsy. Both patients received transconjunctival lacrimal gland Incobotulinum toxin A (INCO BTX-A, Xeomin®) injection, with dosage range from 5- 16 units (U). Outcomes were measured by treatment efficacy and adverse drug effects. Both patients reported resolution of gustatory lacrimation post treatment. The patient who was treated with 16U experienced transient ptosis and diplopia following injection. While the patient treated with 5-7.5 U experienced no adverse effects. We conclude that transconjunctival lacrimal gland INCO BTX-A injection is efficacious treatment for CTS. Utilizing lower doses of botulinum toxin may have a more favorable side effect profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lacrimal ApparatusBotulinum Toxins, Type ANeuromuscular AgentsLacrimal Apparatus DiseasesFacial ParalysisBell PalsyAutonomic Nervous System DiseasesToxins, BiologicalCongenital Cranial Dysinnervation DisordersBlepharoptosisJaw AbnormalitiesReflex, AbnormalHumans

Substanzen

Botulinum Toxins, Type ANeuromuscular AgentsToxins, Biological

Autor:innen und Institutionen

  • School of Medicine, Uniformed Services University, Bethesda, Maryland.
  • Department of Ophthalmology, Madigan Army Medical Center, Tacoma, Washington.

Zitieren

APA

Krivda, K., Clabeaux, C., & Yakopson, V. (2023). Crocodile tear syndrome treated with lacrimal gland incobotulinum toxin A injection: a case series. Digital Journal of Ophthalmology. https://doi.org/10.5693/djo.02.2023.09.001

Vancouver

Krivda K, Clabeaux C, Yakopson V. Crocodile tear syndrome treated with lacrimal gland incobotulinum toxin A injection: a case series. Digital Journal of Ophthalmology. 2023. doi:10.5693/djo.02.2023.09.001

BibTeX
@article{Krivda2023,
  author = {Krivda, Kathleen and Clabeaux, Carson and Yakopson, Vladimir},
  title = {Crocodile tear syndrome treated with lacrimal gland incobotulinum toxin A injection: a case series},
  journal = {Digital Journal of Ophthalmology},
  year = {2023},
  doi = {10.5693/djo.02.2023.09.001}
}
Kostenlos starten →